Similar articles

• High serum levels of norovirus genotype-specific blocking antibodies correlate with protection from infection in children.

  Malm M, Uusi-Kerttula H, Vesikari T, Blazevic V. Malm M, et al. J Infect Dis. 2014 Dec 1;210(11):1755-62. doi: 10.1093/infdis/jiu361. Epub 2014 Jun 26. J Infect Dis. 2014. PMID: 24970849
• Induction of homologous and cross-reactive GII.4-specific blocking antibodies in children after GII.4 New Orleans norovirus infection.

  Blazevic V, Malm M, Vesikari T. Blazevic V, et al. J Med Virol. 2015 Oct;87(10):1656-61. doi: 10.1002/jmv.24237. Epub 2015 May 6. J Med Virol. 2015. PMID: 25946711
• Seroprevalence of antibodies against GII.4 norovirus among children in Pune, India.

  Kulkarni R, Lole K, Chitambar SD. Kulkarni R, et al. J Med Virol. 2016 Sep;88(9):1636-40. doi: 10.1002/jmv.24495. Epub 2016 Feb 24. J Med Virol. 2016. PMID: 26868418
• The evolution of norovirus, the "gastric flu".

  Lopman B, Zambon M, Brown DW. Lopman B, et al. PLoS Med. 2008 Feb;5(2):e42. doi: 10.1371/journal.pmed.0050042. PLoS Med. 2008. PMID: 18271623 Free PMC article. Review.
• Noroviruses: epidemiology, immunity and prospects for prevention.

  Pringle K, Lopman B, Vega E, Vinje J, Parashar UD, Hall AJ. Pringle K, et al. Future Microbiol. 2015;10(1):53-67. doi: 10.2217/fmb.14.102. Future Microbiol. 2015. PMID: 25598337 Review.